We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$216M
Cap. Flow
-$62.5M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.94%
Holding
294
New
29
Increased
89
Reduced
98
Closed
32

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$46.6M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
BCR
CR Bard Inc.
BCR
+$31.1M
4
CVS icon
CVS Health
CVS
+$27.8M
5
DHR icon
Danaher
DHR
+$26.6M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.5M
2
PNC icon
PNC Financial Services
PNC
+$34.3M
3
CELG
Celgene Corp
CELG
+$32.4M
4
AGN
Allergan plc
AGN
+$28M
5
CNC icon
Centene
CNC
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 23.21%
3 Financials 21.91%
4 Communication Services 9.94%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOC icon
201
Healthpeak Properties
DOC
$15.4B
$1.63M 0.03%
54,900
– –
EWBC icon
202
East-West Bancorp
EWBC
$17.9B
$1.62M 0.03%
50,000
-31,000
-38% -$1.01M
TWO
203
Two Harbors Investment
TWO
$1.27B
$1.59M 0.03%
25,000
– –
AGN
204
DELISTED
Allergan plc
AGN
$1.55M 0.03%
5,782
-97,718
-94% -$28M
HL icon
205
Hecla Mining
HL
$10B
$1.54M 0.03%
+550,000
New +$1.24M
QLYS icon
206
Qualys
QLYS
$4.81B
$1.54M 0.03%
61,002
-66,501
-52% -$1.72M
SBRA icon
207
Sabra Healthcare REIT
SBRA
$5.66B
$1.5M 0.03%
75,000
– –
NVDQ
208
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.44M 0.03%
130,000
– –
HCSG icon
209
Healthcare Services Group
HCSG
$1.57B
$1.41M 0.03%
38,372
– –
PCRX icon
210
Pacira BioSciences
PCRX
$1.05B
$1.38M 0.03%
26,034
+5,045
+24% +$295K
RDUS
211
DELISTED
Radius Health, Inc.
RDUS
$1.22M 0.02%
38,689
+29,380
+316% +$1.02M
MIME
212
DELISTED
Mimecast Limited
MIME
$1.13M 0.02%
+116,432
New +$1.08M
TTWO icon
213
Take-Two Interactive
TTWO
$44.8B
$1.12M 0.02%
+30,000
New +$1.04M
HDB icon
214
HDFC Bank
HDB
$119B
$1.1M 0.02%
71,608
– –
MTLS
215
Materialise
MTLS
$376M
$1.07M 0.02%
140,779
-29,852
-17% -$199K
VRTX icon
216
Vertex Pharmaceuticals
VRTX
$122B
$1.03M 0.02%
12,913
-5,290
-29% -$478K
NSTG
217
DELISTED
NanoString Technologies, Inc.
NSTG
$989K 0.02%
+65,000
New +$919K
MO icon
218
Altria Group
MO
$122B
$971K 0.02%
15,500
– –
AA icon
219
Alcoa
AA
$11.7B
$943K 0.02%
+40,974
New +$834K
VIVO
220
DELISTED
Meridian Bioscience Inc
VIVO
$882K 0.02%
42,800
– –
CSLT
221
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$871K 0.02%
261,458
– –
RARE icon
222
Ultragenyx Pharmaceutical
RARE
$2.67B
$838K 0.02%
13,232
-196,768
-94% -$12.9M
ISEE
223
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$817K 0.02%
+19,320
New +$984K
CASH icon
224
Pathward Financial
CASH
$1.82B
$793K 0.01%
52,146
-11,652
-18% -$161K
ACOR
225
DELISTED
Acorda Therapeutics
ACOR
$768K 0.01%
242
-52
-18% -$216K
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Polar Capital held 294 positions worth $5.32B, down 3.9% from $5.53B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2016 filing shows 29 new, 89 increased, 98 reduced and 32 closed positions. Its largest new stake was Union Pacific: 603,004 shares worth $48M. The largest sale was Bristol-Myers Squibb, an estimated $36.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2016 buy was Union Pacific: 603,004 shares worth $48M.
  • Polar Capital added most to Gilead Sciences in Q1 2016, an estimated $37M increase.
  • Polar Capital's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $36.5M.
  • Polar Capital fully exited Centene in Q1 2016, selling an estimated $27.3M.
  • Polar Capital's ten largest holdings make up 24% of its $5.32B portfolio in Q1 2016.
  • Polar Capital opened 29 new positions and closed 32 in Q1 2016.
  • Polar Capital's portfolio value fell 3.9% quarter-over-quarter to $5.32B.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.